Cargando…
Landscape of RB1 alterations in 22,432 Chinese solid tumor patients
BACKGROUND: The human retinoblastoma susceptibility gene (RB1) is a tumor-suppressor gene mutated at different frequencies in many different cancers. The aim of the present study was to investigate the distribution of overall RB1 mutation and different mutation types in a range of Chinese patients w...
Autores principales: | Xu, Guanghui, Zheng, Jiyang, Wang, Shu, Wang, Yuhao, Li, Guixiang, Wang, Nan, She, Xueke, Duan, Weiming, Zhang, Hushan, Huang, Depei, Bei, Ting, Fu, Dan, Yang, Jianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469137/ https://www.ncbi.nlm.nih.gov/pubmed/36110997 http://dx.doi.org/10.21037/atm-22-3162 |
Ejemplares similares
-
M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
por: Wang, Shu, et al.
Publicado: (2023) -
The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review
por: Ning, Xiangu, et al.
Publicado: (2021) -
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
por: Zhao, Xiaolong, et al.
Publicado: (2021) -
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis
por: Yang, Jun, et al.
Publicado: (2021) -
A small-scale, exploratory real-world study of nab-paclitaxel combined with oxaliplatin and tegafur in the perioperative treatment of advanced gastric cancer: a study protocol for a real-world clinical trial
por: Zheng, Jiyang, et al.
Publicado: (2023)